Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Current Value
$17.361 Year Return
Current Value
$17.361 Year Return
Market Cap
$1.51B
P/E Ratio
-3.82
1Y Stock Return
207.79%
1Y Revenue Growth
-2.96%
Dividend Yield
0.00%
Price to Book
-44.5
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Finnhub
NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Travere Therapeutics, Inc. . Such investors are advised to contact Danielle Peyton at...
Yahoo
The United States market has been flat in the last week yet it is up 32% over the past year with earnings forecast to grow by 15% annually. In this context, identifying high growth tech stocks that align with these robust market conditions can be crucial for investors looking to capitalize on potential opportunities.
Yahoo
SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that on November 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants to six new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 24,400 shares of its common stock. These inducement RSUs are subject to the terms of Travere’s 2018 Equity Incentive Plan (“2018 Plan”) but were granted outside of the 2018 Plan
Yahoo
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced the completion of its previously announced underwritten public offering of 8,984,375 shares of its common stock at a price to the public of $16.00 per share, including 1,171,875 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares. All of the shares were sold by Travere. Including the option exercise, the aggregate gross proceeds from the offeri
Finnhub
Travere Therapeutics Announces Proposed Public Offering of Common Stock SAN DIEGO, November 7, 2024 - Travere Therapeutics, Inc. today announced that it intends to offer and...
Yahoo
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced the pricing of an underwritten public offering of 7,812,500 shares of its common stock at a price to the public of $16.00 per share. All of the shares are being sold by Travere. The gross proceeds from the offering are expected to be $125.0 million, before deducting the underwriting discounts and commissions and offering expenses. The offering is expected to close on November 12, 2024, subject
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CHD | -<0.01% | $27.18B | +19.50% | 1.03% |
AAP | 0.01% | $2.30B | -24.49% | 2.57% |
HEAR | 0.01% | $300.79M | +44.04% | 0.00% |
PGR | 0.03% | $149.10B | +57.29% | 0.45% |
CVE | 0.06% | $29.32B | -10.19% | 2.95% |
PAC | -0.09% | $8.16B | +31.59% | 0.00% |
API | -0.11% | $299.01M | +33.12% | 0.00% |
WPRT | 0.11% | $76.83M | -36.88% | 0.00% |
LTRN | -0.12% | $33.22M | -22.61% | 0.00% |
CNC | -0.12% | $29.19B | -21.56% | 0.00% |
GHM | 0.13% | $464.78M | +132.21% | 0.00% |
MVO | -0.15% | $106.15M | -22.78% | 16.78% |
APT | -0.18% | $58.84M | +13.35% | 0.00% |
AIFU | 0.22% | $67.49M | -83.02% | 0.00% |
SRG | 0.27% | $221.13M | -55.94% | 0.00% |
QTTB | -0.30% | $354.34M | +188.64% | 0.00% |
SAVA | 0.31% | $1.35B | +25.50% | 0.00% |
PTEN | -0.31% | $3.16B | -31.96% | 3.93% |
MMC | 0.32% | $108.41B | +10.89% | 1.37% |
EQNR | -0.34% | $64.72B | -22.63% | 5.56% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TCTM | -16.12% | $8.10M | -42.99% | 0.00% |
GAN | -15.42% | $83.39M | +21.19% | 0.00% |
STG | -14.30% | $35.67M | +7.92% | 0.00% |
CME | -14.27% | $82.76B | +9.21% | 1.98% |
MCK | -13.28% | $78.15B | +35.51% | 0.42% |
ARLP | -12.11% | $3.54B | +26.77% | 10.11% |
ORLY | -11.59% | $69.31B | +22.06% | 0.00% |
COR | -11.48% | $47.48B | +21.20% | 0.86% |
SEG | -9.90% | $319.72M | +12.41% | 0.00% |
HUSA | -9.47% | $16.69M | -11.56% | 0.00% |
DK | -9.39% | $1.14B | -34.04% | 5.64% |
MPC | -9.22% | $51.04B | +7.57% | 1.57% |
WM | -9.06% | $87.92B | +27.58% | 1.34% |
IMO | -8.78% | $39.72B | +31.84% | 2.23% |
LPLA | -8.74% | $23.55B | +38.13% | 0.38% |
MOH | -8.71% | $16.16B | -21.56% | 0.00% |
GNK | -8.52% | $735.44M | +16.37% | 9.95% |
HES | -8.36% | $45.06B | +1.32% | 1.24% |
NUS | -8.29% | $377.31M | -55.82% | 7.56% |
TXO | -8.27% | $737.26M | -1.80% | 13.22% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RLAY | 44.66% | $803.44M | -39.70% | 0.00% |
RPTX | 39.73% | $122.43M | -39.50% | 0.00% |
PGEN | 39.27% | $228.91M | -28.00% | 0.00% |
AKRO | 38.29% | $2.17B | +93.09% | 0.00% |
ALEC | 38.03% | $377.04M | -19.46% | 0.00% |
KYMR | 37.64% | $2.77B | +125.95% | 0.00% |
ALE | 36.84% | $3.73B | +17.43% | 4.38% |
XNCR | 36.64% | $1.65B | +27.73% | 0.00% |
MNKD | 36.43% | $1.89B | +84.91% | 0.00% |
TCBK | 35.84% | $1.55B | +31.56% | 2.74% |
KROS | 34.56% | $2.17B | +73.87% | 0.00% |
CRNX | 34.38% | $5.12B | +84.27% | 0.00% |
FOLD | 34.03% | $2.84B | -11.52% | 0.00% |
PLRX | 33.70% | $778.32M | -9.55% | 0.00% |
AXSM | 33.54% | $4.63B | +61.30% | 0.00% |
TGTX | 33.41% | $4.72B | +146.10% | 0.00% |
PTGX | 33.29% | $2.30B | +122.64% | 0.00% |
BWIN | 33.26% | $2.99B | +140.33% | 0.00% |
RCKT | 33.07% | $1.20B | -39.83% | 0.00% |
PTCT | 32.65% | $3.04B | +80.14% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 48.82% | $6.58B | 0.35% |
PTH | 44.42% | $143.31M | 0.6% |
IBB | 42.76% | $6.66B | 0.45% |
PBE | 40.36% | $258.53M | 0.58% |
XPH | 39.77% | $157.87M | 0.35% |
FBT | 39.37% | $1.11B | 0.56% |
GNOM | 37.63% | $70.59M | 0.5% |
IWC | 37.21% | $933.99M | 0.6% |
CWB | 36.55% | $3.94B | 0.4% |
IBUY | 36.33% | $176.17M | 0.65% |
BBH | 36.17% | $397.87M | 0.35% |
IWO | 35.18% | $12.56B | 0.24% |
FYX | 35.01% | $959.00M | 0.6% |
YLD | 35.01% | $247.93M | 0.39% |
SMDV | 34.62% | $754.57M | 0.4% |
IHE | 34.34% | $596.23M | 0.39% |
IJR | 34.32% | $90.05B | 0.06% |
SPSM | 34.19% | $12.72B | 0.03% |
VIOO | 34.10% | $3.12B | 0.1% |
XSW | 34.05% | $402.79M | 0.35% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBMF | -0.33% | $1.02B | 0.85% |
CMDY | -0.49% | $279.14M | 0.28% |
XHLF | 0.63% | $874.27M | 0.03% |
HDRO | -0.75% | $164.26M | 0.3% |
SEIX | 0.95% | $268.81M | 0.62% |
FMF | 1.06% | $244.61M | 0.95% |
HIGH | -1.39% | $302.78M | 0.51% |
XLE | 1.39% | $37.90B | 0.09% |
TPMN | -1.46% | $40.60M | 0.65% |
GCC | 1.53% | $133.23M | 0.55% |
CSHI | 1.53% | $482.85M | 0.38% |
KCCA | -1.66% | $220.51M | 0.87% |
SOYB | -1.94% | $27.32M | 0.22% |
DRLL | 1.98% | $336.91M | 0.41% |
IXC | 2.08% | $2.20B | 0.41% |
SGOV | -2.19% | $27.53B | 0.09% |
IEO | 2.42% | $658.25M | 0.4% |
IYE | 2.66% | $1.35B | 0.39% |
VDE | 2.69% | $8.33B | 0.1% |
TAIL | -2.76% | $67.98M | 0.59% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -24.41% | $388.04M | 1.43% |
VIXY | -19.40% | $195.31M | 0.85% |
EQLS | -16.10% | $76.08M | 1% |
DBE | -14.98% | $50.13M | 0.77% |
KMLM | -14.28% | $353.87M | 0.9% |
UUP | -13.84% | $309.25M | 0.77% |
GSG | -13.13% | $914.42M | 0.75% |
COMT | -12.63% | $829.06M | 0.48% |
DBO | -12.48% | $217.57M | 0.77% |
USCI | -12.31% | $185.47M | 1.07% |
FTGC | -11.99% | $2.17B | 1.02% |
PDBC | -11.73% | $4.40B | 0.59% |
DBC | -11.67% | $1.39B | 0.87% |
CTA | -11.64% | $350.27M | 0.78% |
DBA | -11.53% | $755.88M | 0.93% |
USDU | -11.46% | $201.97M | 0.5% |
BOXX | -11.39% | $4.43B | 0.1949% |
KRBN | -10.28% | $242.47M | 0.85% |
TBIL | -6.74% | $4.38B | 0.15% |
WEAT | -6.11% | $120.27M | 0.28% |